# Octapharma Plasma, Inc. – FDA Inspection, May 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f87985e4-a3e3-46b7-b8b5-fedd7caade3e
Source feed: FDA_Inspections

> FDA inspection 1089185 of Octapharma Plasma, Inc., May 09, 2019. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 606, 610, 630 and 640. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089185
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2019-05-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 7

## Related Documents

- FDA Inspection 1018343 - 2017-03-01
- FDA Inspection 913755 - 2015-02-11
- FDA Inspection 853429 - 2013-10-31

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elmina-e-akwo/ecd9066d-1647-4765-ad86-dbe5280241c5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/c384ed6f-a544-42af-8073-ae590af7c2c4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d